AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...

Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The beginning of March saw that rarest of events, a substantial secondary public offering of stock from a European biotech company ... more flexibility in raising finance than in the past.

Korea will create a 34 trillion won ($23.4 billion) fund to bolster high-tech sectors like EV batteries and biotechnology.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

The macroenvironment in 2025 looks grim as signs of a slowdown in the economy set in. The biotech industry experienced a choppy ride in 2024, and the same is likely in store in 2025. Given the ...

Danish biotech company Enduro Genetics has secured €12 million in Series A funding for a new patented "synthetic addiction" ...

Additionally, Goldstein notes that it is currently unclear how the biotech sector could be impacted if Robert F. Kennedy Jr. gets confirmed as Secretary of Health and Human Services (HHS), who fielded ...

Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in 2025 Commitment is part of the European ...